SEC16A
Basic information
Region (hg38): 9:136440096-136483759
Previous symbols: [ "KIAA0310" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEC16A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 18 | ||||
missense | 132 | 18 | 159 | |||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 1 | |||||
Total | 0 | 0 | 134 | 32 | 15 |
Variants in SEC16A
This is a list of pathogenic ClinVar variants found in the SEC16A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-136440101-G-C | Likely benign (Jul 09, 2018) | |||
9-136441762-A-G | not specified | Uncertain significance (Apr 11, 2023) | ||
9-136441788-C-G | not specified | Uncertain significance (Mar 25, 2024) | ||
9-136441804-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
9-136441809-G-A | Benign (Jul 19, 2018) | |||
9-136443851-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
9-136443891-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
9-136445068-C-G | not specified | Uncertain significance (Aug 22, 2023) | ||
9-136445069-T-A | not specified | Uncertain significance (Apr 18, 2023) | ||
9-136445077-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
9-136445078-G-C | not specified | Uncertain significance (Mar 16, 2022) | ||
9-136445105-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
9-136445107-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
9-136446907-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
9-136447248-T-C | Benign (Nov 13, 2018) | |||
9-136447268-G-C | not specified | Uncertain significance (Jun 02, 2023) | ||
9-136447269-C-T | not specified | Uncertain significance (Feb 14, 2024) | ||
9-136447279-G-A | Likely benign (May 03, 2018) | |||
9-136447296-C-T | not specified | Uncertain significance (May 17, 2023) | ||
9-136447595-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
9-136447625-G-A | not specified | Uncertain significance (Nov 05, 2021) | ||
9-136447631-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
9-136447631-G-C | not specified | Uncertain significance (Feb 03, 2022) | ||
9-136447675-T-A | not specified | Uncertain significance (Jun 19, 2024) | ||
9-136451271-C-T | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SEC16A | protein_coding | protein_coding | ENST00000313050 | 30 | 37593 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.360 | 0.640 | 124574 | 0 | 75 | 124649 | 0.000301 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.472 | 1458 | 1.41e+3 | 1.04 | 0.0000872 | 15157 |
Missense in Polyphen | 434 | 473.1 | 0.91736 | 5336 | ||
Synonymous | -3.06 | 701 | 605 | 1.16 | 0.0000448 | 4899 |
Loss of Function | 7.06 | 22 | 97.0 | 0.227 | 0.00000479 | 1110 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000982 | 0.000953 |
Ashkenazi Jewish | 0.000424 | 0.000398 |
East Asian | 0.000343 | 0.000334 |
Finnish | 0.000285 | 0.000278 |
European (Non-Finnish) | 0.000263 | 0.000257 |
Middle Eastern | 0.000343 | 0.000334 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000335 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Defines endoplasmic reticulum exit sites (ERES) and is required for secretory cargo traffic from the endoplasmic reticulum to the Golgi apparatus. SAR1A-GTP-dependent assembly of SEC16A on the ER membrane forms an organized scaffold defining an ERES. Required for normal transitional endoplasmic reticulum (tER) organization. {ECO:0000269|PubMed:17005010, ECO:0000269|PubMed:17192411}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;TNFalpha;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.999
- rvis_EVS
- -2.29
- rvis_percentile_EVS
- 1.23
Haploinsufficiency Scores
- pHI
- 0.191
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.743
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sec16a
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;endoplasmic reticulum organization;Golgi organization;substantia nigra development;protein exit from endoplasmic reticulum;response to endoplasmic reticulum stress;Golgi to plasma membrane CFTR protein transport;COPII vesicle coating;protein stabilization;positive regulation of protein exit from endoplasmic reticulum;protein localization to endoplasmic reticulum exit site;protein localization to plasma membrane
- Cellular component
- Golgi membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;cytosol;ER to Golgi transport vesicle membrane;organelle membrane;perinuclear region of cytoplasm;endoplasmic reticulum exit site
- Molecular function
- protein binding